OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dapagliflozin protects the kidney in a non-diabetic model of cardiorenal syndrome
Konrad Urbanek, Donato Cappetta, Gabriella Bellocchio, et al.
Pharmacological Research (2023) Vol. 188, pp. 106659-106659
Open Access | Times Cited: 37

Showing 26-50 of 37 citing articles:

GLP-1 receptor agonists and SGLT2 inhibitors: new anti-aging tools?
Gaetano Santulli, Pasquale Mone, Fahimeh Varzideh
Future Cardiology (2024), pp. 1-4
Open Access | Times Cited: 1

Small Molecules Targeting Kidney ClC-K Chloride Channels: Applications in Rare Tubulopathies and Common Cardiovascular Diseases
Maria Antonietta Coppola, Michael Pusch, Paola Imbrici, et al.
Biomolecules (2023) Vol. 13, Iss. 4, pp. 710-710
Open Access | Times Cited: 3

The Impact of Pharmacotherapy for Heart Failure on Oxidative Stress—Role of New Drugs, Flozins
П Н Боднар, M Mazurkiewicz, Tomasz Chwalba, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2236-2236
Open Access | Times Cited: 3

Immunolocalization of Sphingolipid Catabolism Enzymes along the Nephron: Novel Early Urinary Biomarkers of Renal Damage
Martha Franco, Agustina Cano-Martı́nez, María del Pilar Ramos‐Godínez, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16633-16633
Open Access | Times Cited: 2

Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases
Ivana Vaněčková, Josef Zicha
Physiological Research (2024), Iss. Suppl 1, pp. S377-S387
Open Access

The effect of dapagliflozin ointment on induced psoriasis in an experimental model
Waleed Khaled Younis Al Bahadly, Ahlem Bdioui, Moaed E. Al‐Gazally, et al.
Journal of Medicine and Life (2024) Vol. 17, Iss. 3, pp. 281-285
Open Access

Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: lessons from preclinical studies
Rayla Rodrigues Soares, Larissa Freitas Viggiani, Juliano Moreira Reis Filho, et al.
Chemico-Biological Interactions (2024) Vol. 403, pp. 111229-111229
Closed Access

The Potential Preventive Role of Dapagliflozin and Metformin Alone or in Combination on the Cisplatin-Induced Renal Damage in Adult Male Albino Rats
Waseem Hassan, Mohamed G. Hamama, Amal Abd El-Khalek Mahdy, et al.
Journal of Microscopy and Ultrastructure (2024)
Closed Access

Cardio and neuro protection by renin angiotensin aldosterone system-focus inhibition angiotensin converting enzyme: A systematic review
Rafiastiana Capritasari, Akrom Akrom, Arif Budi Setianto
BIO Web of Conferences (2024) Vol. 148, pp. 01006-01006
Open Access

Renal outcomes after contrast exposure in patients with diabetes who use sodium–glucose cotransporter 2 inhibitors
Chih‐Wei Chen, Fu-You Su, Pingping Wang, et al.
Postgraduate Medical Journal (2023) Vol. 100, Iss. 1181, pp. 142-150
Closed Access | Times Cited: 1

Initial Phase of Anthracycline Cardiotoxicity Involves Cardiac Fibroblasts Activation and Metabolic Switch
Marialucia Telesca, Maria Donniacuo, Gabriella Bellocchio, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 53-53
Open Access | Times Cited: 1

Previous Page - Page 2

Scroll to top